Necrolytic migratory erythema following prolonged continuous subcutaneous dasiglucagon administration: a rare dermatologic adverse event

Clinical management of congenital hyperinsulinism (CHI) remains a significant challenge due to its complex pathophysiology and the limitations of available therapies. Dasiglucagon, a synthetic glucagon analog, represents a novel approach to managing CHI, particularly in patients where conventional t...

全面介紹

書目詳細資料

發表在:	Endocrinology, Diabetes & Metabolism Case Reports
Main Authors:	Lucas Weschle, Jenny Potratz, Frank Rutsch, Alexander Humberg, Sandra Oesingmann, Andreas Pascher, Alexander S Busch, Katja Masjosthusmann
格式:	Article
語言:	英语
出版:	Bioscientifica 2025-04-01
主題:	necrolytic migratory erythema dasiglucagon congenital hyperinsulinism neonatal hypoglycemia
在線閱讀:	https://edm.bioscientifica.com/view/journals/edm/2025/2/EDM-25-0006.xml